MENU
CAH
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

CAH stock forecast, quote, news & analysis

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers... Show more

CAH
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement

Why Cardinal Health (CAH) Stock Is Up +17% in the Last 30 Days

Key Takeaways

  • Cardinal Health (CAH) shares rose approximately 17.46% over the past 30 days, significantly outperforming broader market benchmarks.
  • The stock reached new 52-week highs near $240 amid strong momentum and favorable analyst sentiment.
  • Quarterly earnings beats and robust full-year EPS growth projections of 30.58% year-over-year have supported the advance.
  • Positive Zacks Rank of #2 (Buy) and sector positioning in medical distribution contributed to investor interest.
  • Broader healthcare distribution trends and consistent operational performance served as key supporting factors.

Cardinal Health (CAH) Company Overview and Market Position

Cardinal Health is a leading healthcare services and products company that distributes pharmaceuticals, medical supplies, and laboratory products to hospitals, pharmacies, and other healthcare providers. Its business model centers on efficient supply chain management, specialty pharmaceutical services, and data-driven solutions that help clients optimize inventory and reduce costs. The company holds a strong competitive position in the medical distribution industry alongside peers such as McKesson and AmerisourceBergen, benefiting from scale, long-term customer relationships, and diversified revenue streams across its Pharmaceutical and Medical segments.

Cardinal Health (CAH) Stock Price Performance: Last 30 Days vs. Quarter

Over the past 30 days, CAH advanced roughly 17.46%, closing near $236–$238 levels after trading as high as $240.93. This marks a notable acceleration from earlier in the year. For the quarter, the stock posted gains consistent with its year-to-date return of approximately 16%, reflecting sustained upward momentum driven by earnings strength and sector tailwinds rather than isolated short-term spikes.

What Drove CAH Stock Price in the Last 30 Days

The recent advance was supported by continued earnings momentum, with the company reporting quarterly results that exceeded expectations. Analysts highlighted robust full-year EPS projections of $10.76, representing 30.58% year-over-year growth. Positive sentiment was reinforced by the stock’s Zacks Rank of #2 (Buy) and proximity to all-time highs. Sector rotation toward healthcare distributors and steady demand for pharmaceutical and medical products also contributed to the price appreciation.

What Drove CAH Stock Performance Over the Last Quarter

Throughout the quarter, Cardinal Health benefited from consistent operational execution, earnings beats, and favorable industry dynamics in medical distribution. Revenue growth and margin stability, alongside broader healthcare utilization trends, helped maintain investor confidence. The company’s established market position and recurring revenue model provided resilience amid macroeconomic variables, supporting a steady upward trajectory.

Trending AI Robots

Tickeron’s Trending AI Robots page showcases a curated selection of the platform’s top-performing AI trading bots. While Tickeron offers hundreds of AI trading bots that analyze and trade thousands of tickers across various markets, only the highest-performing and most relevant bots appear in this focused section. These bots employ diverse strategies and timeframes, with performance metrics that allow users to evaluate historical results and risk parameters. Investors interested in automated trading solutions can explore the full range of options on the platform. Trending AI Robots

CAH Stock Forecast Drivers: What Investors Should Watch Next

Investors should monitor upcoming earnings reports, updates to full-year guidance, and trends in pharmaceutical demand and healthcare utilization. Macroeconomic factors such as interest rates, regulatory developments in drug pricing, and competitive pressures within the distribution sector will also remain relevant. Analyst expectations and institutional positioning provide additional context for potential price movements.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
A.I.Advisor
a Summary for CAH with price predictions
Jun 29, 2026

CAH in upward trend: 10-day moving average crossed above 50-day moving average on June 10, 2026

The 10-day moving average for CAH crossed bullishly above the 50-day moving average on June 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 04, 2026. You may want to consider a long position or call options on CAH as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CAH moved above its 50-day moving average on June 05, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CAH advanced for three days, in of 386 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 290 cases where CAH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CAH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CAH broke above its upper Bollinger Band on June 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. CAH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (19.710). P/E Ratio (34.006) is within average values for comparable stocks, (42.348). Projected Growth (PEG Ratio) (1.379) is also within normal values, averaging (1.285). Dividend Yield (0.009) settles around the average of (0.007) among similar stocks. P/S Ratio (0.212) is also within normal values, averaging (5.989).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

CAH is expected to pay dividends on July 15, 2026

Cardinal Health CAH Stock Dividends
A dividend of $0.52 per share will be paid with a record date of July 15, 2026, and an ex-dividend date of July 01, 2026. The last dividend of $0.51 was paid on April 15. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 17.43B. The market cap for tickers in the group ranges from 557.05K to 87.52B. MCK holds the highest valuation in this group at 87.52B. The lowest valued company is CNBI at 557.05K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was 2%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was -6%. AHG experienced the highest price growth at 13%, while COSM experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was 68%. For the same stocks of the Industry, the average monthly volume growth was 33% and the average quarterly volume growth was 379%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 61
Price Growth Rating: 58
SMR Rating: 89
Profit Risk Rating: 78
Seasonality Score: 12 (-100 ... +100)
View a ticker or compare two or three
CAH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a maker of pharmaceuticals, medical, surgical and laboratory supplies as well as develops drug delivery systems

Industry MedicalDistributors

Profile
Details
Industry
Medical Distributors
Address
7000 Cardinal Place
Phone
+1 614 757-5000
Employees
48000
Web
https://www.cardinalhealth.com
Why Cardinal Health (CAH) Stock Is Up +17% in the Last 30 Days